Clarithromycin IV Dosing for Hemodialysis Patients
For patients on hemodialysis, reduce the clarithromycin dose by 50% (250 mg IV twice daily instead of 500 mg) or double the dosing interval (500 mg IV once daily) when creatinine clearance is <30 mL/min. 1, 2, 3
Dosing Algorithm
Standard Approach (Creatinine Clearance <30 mL/min or Hemodialysis):
- Option 1: 250 mg IV every 12 hours
- Option 2: 500 mg IV every 24 hours
Key Considerations:
Timing with Dialysis:
- The guidelines do not specify whether to administer clarithromycin before or after hemodialysis sessions 1, 2
- Unlike drugs that are significantly dialyzed (like ganciclovir or levofloxacin), clarithromycin dosing timing relative to dialysis is not explicitly addressed in the evidence
Important Caveat:
- When clarithromycin is used concomitantly with atazanavir or ritonavir in patients with moderate to severe renal impairment, more aggressive dose reductions are required 3:
- CrCl 30-60 mL/min: reduce dose by 50%
- CrCl <30 mL/min: reduce dose by 75%
Clinical Context
The evidence consistently shows that clarithromycin requires dose adjustment in severe renal impairment because both the parent drug and its active metabolite (14-hydroxyclarithromycin) accumulate when renal function is compromised 3, 4. The 14-OH metabolite concentrations are particularly affected, with decreased formation but increased accumulation in renal failure.
Practical Implementation:
- Start with 250 mg IV every 12 hours for most hemodialysis patients
- Consider 500 mg IV every 24 hours if twice-daily dosing is impractical
- Monitor for adverse effects (QT prolongation, hepatotoxicity, gastrointestinal symptoms)
- Be vigilant about drug interactions, particularly with CYP3A substrates 5, 4
The 50% dose reduction recommendation is consistent across multiple authoritative guidelines including CDC/IDSA HIV opportunistic infection guidelines 1 and IDSA chronic kidney disease guidelines 2, making this the most reliable approach for hemodialysis patients.